Fujian Shengdi Pharmaceutical Co., Ltd.

This study tested a new tablet called HRS9531 to help people with obesity lose weight. 166 adults with a BMI between 28 and 40 took either the drug or a placebo for 26 weeks. The main goal was to see how much weight they lost compared to those on placebo.

This early-stage study tested a new injection called HRS-4729 in 102 healthy adults who were overweight or obese. The main goal was to check if the drug is safe and how the body processes it. Participants received either the drug or a placebo, and researchers monitored side effec…

This early-stage study tested a new drug called HRS-7450 in 64 adults who had an acute ischemic stroke (a stroke caused by a blood clot). The main goal was to see if the drug is safe and tolerable, especially regarding the risk of bleeding in the brain. Researchers also looked at…

This early-stage study tested a single injection of HRS-7249 in 32 to 48 healthy adults with mildly to moderately high cholesterol. The main goal was to check safety and how the drug moves through the body. Participants received either the drug or a placebo, and researchers monit…

This study tested a new drug called HR20013 against an existing drug (palonosetron) to see which better prevents nausea and vomiting in cancer patients receiving moderate-risk chemotherapy. 706 adults with cancer who had never had chemo before took part. The goal was to see if HR…

This early-stage study tested a new injectable drug, HRS-9057, in 25 adults with heart failure who still had fluid buildup despite taking water pills. The goal was to see if the drug is safe and helps the body remove extra fluid compared to a standard pill (tolvaptan). Participan…

This study looked at how the drug HRS9531 enters and leaves the body in people with different levels of kidney function. Researchers compared 32 adults with normal kidneys to those with mild or moderate kidney impairment. The goal was to understand if kidney problems change how t…

This early-stage study tested a single shot of HRS-5632 in 50 healthy adults to see if it is safe and how the body processes it. The goal was not to treat any disease, but to gather important safety and drug-level information for future studies. Participants were healthy voluntee…